Denali Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-162,703
Closed -$10.3M 330
2019
Q3
$10.3M Sell
162,703
-300
-0.2% -$19.6K 1.44% 22
2019
Q2
$11M Buy
163,003
+20,700
+15% +$1.36M 1.65% 22
2019
Q1
$9.25M Sell
142,303
-18,300
-11% -$1.22M 1.48% 28
2018
Q4
$10M Hold
160,603
1.68% 27
2018
Q3
$12.4M Buy
160,603
+5,200
+3% +$393K 1.82% 25
2018
Q2
$11M Buy
155,403
+14,300
+10% +$1.01M 1.65% 28
2018
Q1
$10.6M Sell
141,103
-200
-0.1% -$15.9K 1.71% 21
2017
Q4
$10.1M Buy
141,303
+1,726
+1% +$131K 1.57% 27
2017
Q3
$11.3M Sell
139,577
-9,300
-6% -$711K 1.87% 19
2017
Q2
$10.5M Sell
148,877
-2,000
-1% -$133K 1.72% 22
2017
Q1
$10.2M Buy
150,877
+25,664
+20% +$1.8M 1.51% 26
2016
Q4
$8.97M Sell
125,213
-52,860
-30% -$3.93M 1.56% 20
2016
Q3
$14.1M Buy
178,073
+42,973
+32% +$3.49M 2.14% 14
2016
Q2
$11.3M Buy
135,100
+114,200
+546% +$10.1M 1.94% 15
2016
Q1
$1.92M Buy
+20,900
New +$1.88M 0.42% 70

Other funds holding GILD

Denali Advisors's GILD Position: Q4 2019 in Review

Denali Advisors sold out of Gilead Sciences (GILD) in Q4 2019, closing a stake of 162,703 shares — an estimated $10.3M sold.

Denali Advisors first reported a position in GILD in Q1 2016 and held it in 15 quarters. The position peaked at $14.1M in Q3 2016. 1,555 funds tracked by Wall St. Rank hold GILD as of Q4 2019.

  • Denali Advisors reported no remaining Gilead Sciences position as of Q4 2019 after selling out during the quarter.
  • Denali Advisors sold 162,703 Gilead Sciences shares in Q4 2019, an estimated $10.3M.
  • Denali Advisors first reported a position in Gilead Sciences in Q1 2016 and held it in 15 quarters.
  • Denali Advisors's Gilead Sciences position peaked at $14.1M in Q3 2016.
  • 1,555 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.

Based on Denali Advisors's 13F filing for Q4 2019, filed 30 Jan 2020.